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store-operated calcium entry; smooth muscle cells; constriction IN CEREBRAL ARTERIES and other small-diameter vessels, voltagegated L-type Ca 2ϩ (Ca L 2ϩ ) channels are known to be the primary channels responsible for agonist-induced constriction, in as much as their inhibition was shown to fully relax most microvessels (19, 20) . On the other hand, depletion of intracellular Ca 2ϩ stores by different agonists [or by inhibitors of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase] activates storeoperated (SOC) channels and store-operated Ca 2ϩ entry (SOCE) in isolated smooth muscle cells (SMC) (for review see Refs. 1, 3, 26) . In conduit vessels, nonselective cation SOC (rather than Ca L 2ϩ channels) play a major role in agonistinduced constriction and nitric oxide-induced relaxation (8, 27) , but the role of SOC in constriction of microvessels, especially in the cerebral circulation, remains unclear. In SMC of cerebral arterioles, activation of SOCE increases Ca 2ϩ but fails to generate constriction (11, 12) , suggesting that SOC may be mediating Ca 2ϩ influx into restricted space (or cellular compartments), which may be spatially separated from the contractile apparatus. In interlobular arteries, SOC are present but do not significantly contribute to Ca 2ϩ entry after agonist stimulation (10) . In numerous other types of SMC, Ca 2ϩ store depletion was reported to increase Ca 2ϩ and cause constriction, although it was studied only using poorly selective SOC inhibitors (for review see Refs. 3 and 14) . Thus the following questions remain. 1) By what mechanism might SOC be involved in the physiological regulation of agonist-induced constriction in microvessels? 2) How might their role be related to activation of Ca L 2ϩ channels. Because of the nonselective cation permeability of SOC in SMC, SOC activation should cause a significant membrane depolarization, which may result in cross talk between SOC and Ca L 2ϩ channels (7); this theory is supported by studies in isolated SMC from guinea pig gallbladder (18) and in the A7r5 cell line (21) , but little is known about their possible cross talk in intact vessels.
Recently, the Ca 2ϩ -independent phospholipase A 2 (iPLA 2 ) ␤ (group VI) (2, 30) was found to be a crucial determinant of SOCE activation in isolated aortic SMC, but the role of iPLA 2 ␤ in intact cerebral and other microvessels is unknown. Functional inhibition of iPLA 2 with its suicidal substrate bromoenol lactone (BEL) or specific antisense oligonucleotides against iPLA 2 ␤ has been shown to produce identical impairment of SOCE in isolated SMC (24, 25) , as well as astrocytes (23) , keratinocytes (22) , skeletal muscle (4), fibroblasts (16) , prostate cancer (28) , and other cell types (24, 25) . The crucial role of iPLA 2 ␤ in SOCE activation was recently confirmed in a screen of Drosophila melanogaster genes (29) , where molecular knockdown of the CG6718 gene (a Drosophila homolog of human iPLA 2 ␤) significantly affected SOCE. In isolated vascular SMC, we discovered that single-cation SOC and SOCE can be activated by lysophospholipids, which are produced by the plasma membrane-bound iPLA 2 ␤ (24). Activation of iPLA 2 ␤ can be physiologically achieved by Ca 2ϩ influx factor, which is produced in endo(sarco)plasmic reticulum on depletion of Ca 2ϩ stores (5) and is capable of displacing inhibitory calmodulin from its binding site on iPLA 2 ␤. Thus agonistinduced depletion of the stores can activate SOC and SOCE in SMC via an iPLA 2 ␤-dependent pathway (24) .
Discovery of iPLA 2 ␤ as a crucial component of the SOCE mechanism in SMC and development of a chiral-specific functional inhibitor of iPLA 2 ␤ (9, 15) have opened new avenues for studying the role of the SOCE mechanism in vascular constriction. In the present study, we have examined the roles of SOC and Ca L 2ϩ channels in microvessels and tested the hypothesis that agonist-induced iPLA 2 -dependent activation of SOC may be required for secondary activation of Ca L 2ϩ and Ca 2ϩ entry, which trigger contractile responses in cerebral, mesenteric, and carotid arteries. Using simultaneous recording of Ca 2ϩ in SMC and vessel diameter, we demonstrate that phenylephrine (PE)-induced constriction fully depends on the functional activity of iPLA 2 ␤ and SOC, as well as Ca L 2ϩ channels. These new findings establish the crucial role of iPLA 2 ␤-dependent SOC in vascular responses to agonist stimulation and provide a new important mechanism of regulation of tone in different microvascular beds.
MATERIALS AND METHODS

Drugs and materials.
Unless otherwise indicated, all drugs were purchased from Sigma. BEL was purchased from Biomol; S-and R-BEL from Cayman Chemicals; and fura 2-AM from Invitrogen. Physiological salt solution (PSS) consisting of (in mM) 119 NaCl, 4.7 KCl, 24 NaHCO 3, 1.2 KH2PO4, 1.6 CaCl2, 1.2 MgSO4, 0.023 EDTA, and 11 glucose was bubbled with 95% O2-5% CO2 to ensure pH 7.4.
Isolation of mouse cerebral and mesenteric and rabbit carotid arteries. Posterior cerebral arteries (PCA) and mesenteric arteries were obtained from male mice (C57BL/6, 8 -10 wk old). First-order PCA and second-order mesenteric arteries (ϳ120 m diameter) were dissected free from the mesenteric arterial bed or brain and connective tissue in ice-cold PSS. Dissected arterial segments (200 m long) were cannulated in a chamber connected to a pressure myograph (Living Systems Instrumentation, Burlington, VT) and immediately used for experiments.
Carotid arteries were obtained from male New Zealand rabbits (3.1 Ϯ 0.4 kg body wt), cleaned of all connective tissue in cold PSS, and mounted onto a myograph (see below).
All research was performed in accordance with the American Physiological Society "Guiding Principles in the Care and Use of Animals" and with Institutional Animal Care and Use Committee approval.
Simultaneous recording of Ca
2ϩ and vessel diameter. Mircovessels were maintained at 37°C throughout the experiment by superfusion with prewarmed, bubbled PSS at a rate of 5 ml/min. Before the experiments, vessels were equilibrated for 20 min at 10 mmHg, then pressure was raised to 60 mmHg; intravascular pressure was controlled by a pressure servo and peristaltic pump (Living Systems Instrumentation). The chamber with the microvessel was mounted on an Olympus microscope equipped with the IonOptix data acquisition system (IonOptix, Milton, MA), which allowed simultaneous measurement of 1) intraluminal diameter using the Softedge Acquisition Subsystem and 2) intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i) using a ratiometric photomultiplier system. Fura 2-AM loading of SMC was accomplished by incubation of the mounted arteries in external PSS containing 5 M fura 2-AM for 50 min at room temperature in the dark. The fura 2-AM ratio (ratio of fura 2 fluorescence at 340-nm excitation to that at 380-nm excitation, with emission at 510 nm) was recorded at a sampling rate of 5 Hz. Arterial diameter and fluorescence ratio were simultaneously recorded and plotted over time.
Isometric tension measurements. Isometric tension was measured as previously described (6, 8) . Briefly, 5-mm-long rings of rabbit carotid artery segments were cleaned of connective tissue and mounted on metal stirrups in organ chambers, and isometric tension was recorded. Rings were maintained at 37°C in bubbled (95% O 2-5% CO2) PSS. Rings were equilibrated and stretched to an optimal tension of 7 g. Pharmacological agents were added to the bath as indicated. Statistical analysis. Summary data are presented as means Ϯ SE. Student's t-test was used to determine the statistical significance of the data. P Ͻ 0.05 was considered significant.
RESULTS
To investigate the role of SOC in contractile responses of microvessels, we first tested and compared the effects of 2-aminoethyl diphenylborinate (2-APB, a widely used SOC inhibitor) and nimodipine (Nim, an inhibitor of Ca L 2ϩ channels) on responses to PE or high K ϩ . [Ca 2ϩ ] i in SMC was measured simultaneously with intraluminal vessel diameter in PCA (Fig.  1) . The high-K ϩ -induced Ca 2ϩ rise and vessel constriction were inhibited by 5 M Nim but were not affected by 75 M 2-APB [which is known to fully inhibit SOC and SOCE in SMC (12) ] i rise and vessel constriction were inhibited by Nim and 2-APB ( Figs. 1 and 2 ), suggesting the involvement of SOC and Ca L 2ϩ channels in agonist-induced responses. To provide new mechanistic insights into the role of SOC activation and the iPLA 2 -mediated SOCE pathway in microvessel constriction, the effect of functional inhibition of iPLA 2 on PE-and K ϩ -induced Ca 2ϩ influx and constriction of cerebral, mesenteric, and carotid arteries was examined. Simultaneous changes in [Ca 2ϩ ] i and vessel diameter in response to consecutive application of K ϩ (60 mM) and PE (10 M) to a cerebral artery are shown in Fig. 3 . After the responses were tested under control conditions, the vessels were treated for 30 min with 25 M BEL, which was previously shown to irreversibly impair iPLA 2 function in SMC (25) . After the vessels were treated with BEL and washed for 10 min, K ϩ and PE were reapplied (Fig. 3) , and the vessels retained a normal response to high K ϩ , but not PE. As shown in Fig. 4A 4B ) and rabbit carotid artery (Fig. 5 ) extended our findings to these additional microvascular beds as well as different types of animals. Figure 5 also demonstrates that inhibition of iPLA 2 not only could prevent agonist-induced constriction but also could relax the preconstricted artery. To confirm that iPLA 2 ␤, and not iPLA 2 ␥, is required for agonist-induced Ca 2ϩ entry and constriction in microvessels, we compared the effects of S-BEL and R-BEL [chiral enantiomers of this suicidal substrate that can discriminate these iPLA 2 isoforms (9, 15)] on PE-induced responses in cerebral arteries. Although vessels pretreated with R-BEL (which is specific to iPLA 2 ␥) responded normally to PE, S-BEL (which is specific to iPLA 2 ␤) totally impaired PE-induced Ca 2ϩ entry and constriction in the same vessels (Fig. 6) . 
DISCUSSION
Our data in intact cerebral, mesenteric, and carotid arteries demonstrate for the first time that iPLA 2 -dependent activation of SOC is essential for agonist-induced Ca 2ϩ entry and constriction in a wide variety of arteries, suggesting that this is a widespread phenomenon in microvessels.
To account for our finding of the equally important role of iPLA 2 ␤, as well as SOC and Ca L 2ϩ channels, we propose a model for agonist-induced responses in microvessels (Fig. 7) . On the basis of our earlier findings in isolated SMC (8, 24) , we propose that agonist stimulation causes depletion of Ca 2ϩ stores and activation of iPLA 2 , which produces lysophospholipids that activate SOC. Nonselective cation SOC (27) can produce significant membrane depolarization and secondary activation of Ca L 2ϩ channels, which cause Ca 2ϩ entry and, in turn, lead to vessel constriction. In this way, Ca L 2ϩ channels and SOC may be equally important for agonist-induced Ca 2ϩ entry in SMC and constriction, as we found in microvessels. In contrast to smaller arteries, in the aorta we found that Ca L 2ϩ channels are not essential for agonist-induced Ca 2ϩ influx and constriction (inhibition of Ca L 2ϩ has little to no effect on aortic tone) (8, 27) . The difference may be explained by an ability of Ca 2ϩ entering through SOC to directly cause contraction in aortic SMC and/or SOC-induced depolarization being insufficient for secondary activation of Ca L 2ϩ channels in SMC of these vessels. sensitization of contractile proteins (13) , which may amplify the effect of the reduction on agonist-induced Ca 2ϩ influx. The use of functional inhibition of iPLA 2 ␤ in our study (in addition to a widely used SOC inhibitor) introduces a new effective way to selectively impair the SOCE pathway in microvascular SMC and provides a more reliable method for assessing the role of SOC in physiology and pathology of microcirculation. Indeed, direct SOC inhibitors (e.g., 2-APB) may not exclude the possibility of involvement of additional A model for agonist-induced Ca 2ϩ entry and constriction of conduit and microvessels. Agonist stimulation triggers inositol trisphosphate (IP3) production and depletion of Ca 2ϩ stores, leading to production of Ca 2ϩ influx factor (CIF). CIF displaces inhibitory calmodulin (CaM) from iPLA2, causing its activation and production of lysophospholipids (LysoPL) and, in turn, activates SOC. Nonselective cation SOC in SMC allow Ca 2ϩ and Na ϩ entry. In conduit vessels, SOC-mediated Ca 2ϩ entry may cause vessel constriction; in microvessels, this pool of Ca 2ϩ may be spatially separated from the contractile apparatus. Instead, in microvessels, SOC-induced depolarization may trigger activation of L-type Ca 2ϩ (Ca L 2ϩ ) channels, which allow Ca 2ϩ entry and, in turn, lead to vessel constriction. Thus SOC may play an important, but slightly different, role in constriction of different vessels: in conduit vessels, SOC allow Ca 2ϩ influx, which is sufficient for constriction; in resistance vessels, SOC serve as a trigger for secondary activation of Ca L 2ϩ channels, which mediate Ca 2ϩ influx and, in turn, cause vessel constriction. IP3R, IP3 receptor; PLC, phospholipase C; ER, endoplasmic reticulum; SR, sarcoplasmic reticulum; SERCA, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase. R, G:G-coupled receptor.
non-SOC, in as much as 2-APB is known to inhibit agonistinduced Ca 2ϩ release (17) , as well as other non-SOC, which could also participate in agonist-induced responses. Recently, we demonstrated (31) that a TRPC1-encoded inositol trisphosphate (IP 3 ) receptor-operated channel (which can be clearly distinguished from SOC) may be activated by agonist-induced IP 3 rise and, potentially, may be involved in SMC and vessel responses to agonists. Importantly, because 2-APB is able to block both channels (SOC and IP 3 receptor-operated channels), it is impossible to distinguish their role in agonist-induced responses solely on the basis of 2-APB-induced inhibition. In our present study, in addition to 2-APB, we used BEL-induced inhibition of iPLA 2 as a selective way to impair SOC activation, in as much as only SOC require its functional activity (4, 9, 16, (22) (23) (24) (25) 28) . BEL (and its chiral enantiomers) provides new specific tools for assessing the role of iPLA 2 ␤ and SOC activation in intact vessels, in which molecular knockdown of proteins poses significant difficulties.
In summary, we have demonstrated that iPLA 2 -dependent activation of SOC, as well as Ca L 2ϩ channels, is crucial for agonist-induced Ca 2ϩ entry and constriction in conduit and microvessels (Fig. 7) .
